Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer

Tomoyoshi Takenaka, Eiko Inamasu, Tsukihisa Yoshida, Gouji Toyokawa, Kaname Nosaki, Fumihiko Hirai, Masafumi Yamaguchi, Takashi Seto, Mitsuhiro Takenoyama, Yukito Ichinose

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: The purpose of this study was to evaluate the outcomes of elderly patients 75 years of age or older with recurrent non-small cell lung cancer (NSCLC). Methods: A total of 1237 consecutive patients with NSCLC underwent pulmonary resection at our institution. Of these patients, 280 experienced postoperative recurrence. The rate of the post-recurrence survival and predictors were analyzed independently in a group of younger patients (<75 years) and a group of elderly patients (≥75 years). Results: There were 215 younger patients (<75 years) and 65 elderly (≥75 years) patients at the time of diagnosis of recurrence. The median post-recurrence survival time and the five-year survival rate of all cases were 25 months and 20.8 %, respectively. There were no significant survival differences between the younger and elderly groups (p = 0.20). A univariate analysis determined that gender, Eastern Cooperative Oncology Group performance status, smoking status, histological type and epithelial growth factor receptor (EGFR) mutation status were factors influencing the post-recurrence survival among the elderly patients. In addition, a multivariate analysis determined the EGFR mutation status to be an independent prognostic factor for the post-recurrence survival. Conclusions: Elderly patients 75 years of age or older in this study achieved satisfactory long-term outcomes.

Original languageEnglish
Pages (from-to)430-436
Number of pages7
JournalSurgery today
Volume46
Issue number4
DOIs
Publication statusPublished - Apr 1 2016

Fingerprint

Non-Small Cell Lung Carcinoma
Recurrence
Survival
Growth Factor Receptors
Mutation
Multivariate Analysis
Survival Rate
Smoking
Lung

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Takenaka, T., Inamasu, E., Yoshida, T., Toyokawa, G., Nosaki, K., Hirai, F., ... Ichinose, Y. (2016). Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer. Surgery today, 46(4), 430-436. https://doi.org/10.1007/s00595-015-1200-9

Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer. / Takenaka, Tomoyoshi; Inamasu, Eiko; Yoshida, Tsukihisa; Toyokawa, Gouji; Nosaki, Kaname; Hirai, Fumihiko; Yamaguchi, Masafumi; Seto, Takashi; Takenoyama, Mitsuhiro; Ichinose, Yukito.

In: Surgery today, Vol. 46, No. 4, 01.04.2016, p. 430-436.

Research output: Contribution to journalArticle

Takenaka, T, Inamasu, E, Yoshida, T, Toyokawa, G, Nosaki, K, Hirai, F, Yamaguchi, M, Seto, T, Takenoyama, M & Ichinose, Y 2016, 'Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer', Surgery today, vol. 46, no. 4, pp. 430-436. https://doi.org/10.1007/s00595-015-1200-9
Takenaka, Tomoyoshi ; Inamasu, Eiko ; Yoshida, Tsukihisa ; Toyokawa, Gouji ; Nosaki, Kaname ; Hirai, Fumihiko ; Yamaguchi, Masafumi ; Seto, Takashi ; Takenoyama, Mitsuhiro ; Ichinose, Yukito. / Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer. In: Surgery today. 2016 ; Vol. 46, No. 4. pp. 430-436.
@article{49775ef316374af3b18a4bba3d8c88f8,
title = "Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer",
abstract = "Purpose: The purpose of this study was to evaluate the outcomes of elderly patients 75 years of age or older with recurrent non-small cell lung cancer (NSCLC). Methods: A total of 1237 consecutive patients with NSCLC underwent pulmonary resection at our institution. Of these patients, 280 experienced postoperative recurrence. The rate of the post-recurrence survival and predictors were analyzed independently in a group of younger patients (<75 years) and a group of elderly patients (≥75 years). Results: There were 215 younger patients (<75 years) and 65 elderly (≥75 years) patients at the time of diagnosis of recurrence. The median post-recurrence survival time and the five-year survival rate of all cases were 25 months and 20.8 {\%}, respectively. There were no significant survival differences between the younger and elderly groups (p = 0.20). A univariate analysis determined that gender, Eastern Cooperative Oncology Group performance status, smoking status, histological type and epithelial growth factor receptor (EGFR) mutation status were factors influencing the post-recurrence survival among the elderly patients. In addition, a multivariate analysis determined the EGFR mutation status to be an independent prognostic factor for the post-recurrence survival. Conclusions: Elderly patients 75 years of age or older in this study achieved satisfactory long-term outcomes.",
author = "Tomoyoshi Takenaka and Eiko Inamasu and Tsukihisa Yoshida and Gouji Toyokawa and Kaname Nosaki and Fumihiko Hirai and Masafumi Yamaguchi and Takashi Seto and Mitsuhiro Takenoyama and Yukito Ichinose",
year = "2016",
month = "4",
day = "1",
doi = "10.1007/s00595-015-1200-9",
language = "English",
volume = "46",
pages = "430--436",
journal = "Surgery Today",
issn = "0941-1291",
publisher = "Springer Japan",
number = "4",

}

TY - JOUR

T1 - Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer

AU - Takenaka, Tomoyoshi

AU - Inamasu, Eiko

AU - Yoshida, Tsukihisa

AU - Toyokawa, Gouji

AU - Nosaki, Kaname

AU - Hirai, Fumihiko

AU - Yamaguchi, Masafumi

AU - Seto, Takashi

AU - Takenoyama, Mitsuhiro

AU - Ichinose, Yukito

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Purpose: The purpose of this study was to evaluate the outcomes of elderly patients 75 years of age or older with recurrent non-small cell lung cancer (NSCLC). Methods: A total of 1237 consecutive patients with NSCLC underwent pulmonary resection at our institution. Of these patients, 280 experienced postoperative recurrence. The rate of the post-recurrence survival and predictors were analyzed independently in a group of younger patients (<75 years) and a group of elderly patients (≥75 years). Results: There were 215 younger patients (<75 years) and 65 elderly (≥75 years) patients at the time of diagnosis of recurrence. The median post-recurrence survival time and the five-year survival rate of all cases were 25 months and 20.8 %, respectively. There were no significant survival differences between the younger and elderly groups (p = 0.20). A univariate analysis determined that gender, Eastern Cooperative Oncology Group performance status, smoking status, histological type and epithelial growth factor receptor (EGFR) mutation status were factors influencing the post-recurrence survival among the elderly patients. In addition, a multivariate analysis determined the EGFR mutation status to be an independent prognostic factor for the post-recurrence survival. Conclusions: Elderly patients 75 years of age or older in this study achieved satisfactory long-term outcomes.

AB - Purpose: The purpose of this study was to evaluate the outcomes of elderly patients 75 years of age or older with recurrent non-small cell lung cancer (NSCLC). Methods: A total of 1237 consecutive patients with NSCLC underwent pulmonary resection at our institution. Of these patients, 280 experienced postoperative recurrence. The rate of the post-recurrence survival and predictors were analyzed independently in a group of younger patients (<75 years) and a group of elderly patients (≥75 years). Results: There were 215 younger patients (<75 years) and 65 elderly (≥75 years) patients at the time of diagnosis of recurrence. The median post-recurrence survival time and the five-year survival rate of all cases were 25 months and 20.8 %, respectively. There were no significant survival differences between the younger and elderly groups (p = 0.20). A univariate analysis determined that gender, Eastern Cooperative Oncology Group performance status, smoking status, histological type and epithelial growth factor receptor (EGFR) mutation status were factors influencing the post-recurrence survival among the elderly patients. In addition, a multivariate analysis determined the EGFR mutation status to be an independent prognostic factor for the post-recurrence survival. Conclusions: Elderly patients 75 years of age or older in this study achieved satisfactory long-term outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84959126483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959126483&partnerID=8YFLogxK

U2 - 10.1007/s00595-015-1200-9

DO - 10.1007/s00595-015-1200-9

M3 - Article

VL - 46

SP - 430

EP - 436

JO - Surgery Today

JF - Surgery Today

SN - 0941-1291

IS - 4

ER -